As of 2024-12-13, the Fair Value of Terns Pharmaceuticals Inc (TERN) is -5.18 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.70 USD, the upside of Terns Pharmaceuticals Inc is -177.38%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -68.61 | -40.05 | -50.16 | -60.35 | -90.21 | -61.88 |
| YoY growth | -287.41% | 41.63% | -25.24% | -20.31% | -49.48% | -68.16% |
| Market Cap (mil) | 569.10 |
| P/E | |
| Forward P/E |
| EPS | -1.04 |
| Avg earnings growth rate | -68.16% |
| TTM earnings | -88.07 |